Fachrepositorium Lebenswissenschaften

41 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

2023 . Blüher, Matthias | Rosenstock, Julio | Hoefler, Josef | Manuel, Raymond | Hennige, Anita

Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients

2022 . Böhm, Anna-Katharina | Schneider, Udo | Stargardt, Tom

Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

2021 . Täger, Tobias | Frankenstein, Lutz | Atar, Dan | Agewall, Stefan | Frey, Norbert | Grundtvig, Morten | Clark, Andrew L. | Cleland, John G. F. | Fröhlich, Hanna

The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis

2021 . Yuan, Zhen | Heng, Zhijian | Lu, Yi | Wei, Jia | Cai, Zhejun

SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?

2021 . Pabel, Steffen | Hamdani, Nazha | Luedde, Mark | Sossalla, Samuel

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

2021 . Pistrosch, Frank | Matschke, Jan B. | Schipp, Dorothea | Schipp, Bernhard | Henkel, Elena | Weigmann, Ingo | Sradnick, Jan | Bornstein, Stefan R. | Birkenfeld, Andreas L. | Hanefeld, Markolf

Pharmacogenetics of novel glucose-lowering drugs

2021 . Rathmann, Wolfgang | Bongaerts, Brenda

New antidiabetic therapy and HFpEF: light at the end of tunnel?

2021 . Tadic, Marijana | Sala, Carla | Saeed, Sahrai | Grassi, Guido | Mancia, Giuseppe | Rottbauer, Wolfang | Cuspidi, Cesare

Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

2021 . Ott, Christian | Jung, Susanne | Korn, Manuel | Kannenkeril, Dennis | Bosch, Agnes | Kolwelter, Julie | Striepe, Kristina | Bramlage, Peter | Schiffer, Mario | Schmieder, Roland

Seiten